NCT02780882View on ClinicalTrials.gov

SOM230 Ectopic ACTH-producing Tumors

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

June 30, 2019

Conditions
Ectopic ACTH Syndrome
Interventions
DRUG

Pasireotide

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Cedars-Sinai Medical Center

OTHER